David L. Krasne

2.0k total citations · 1 hit paper
15 papers, 1.5k citations indexed

About

David L. Krasne is a scholar working on Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David L. Krasne has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David L. Krasne's work include Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Prostate Cancer Treatment and Research (3 papers). David L. Krasne is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers) and Prostate Cancer Treatment and Research (3 papers). David L. Krasne collaborates with scholars based in United States. David L. Krasne's co-authors include Roderick R. Turner, Armando E. Giuliano, Donald L. Morton, Paul S. Dale, David W. Ollila, Donald L. Morton, Charles Lombard, Henry D. Tazelaar, Dave S.�B. Hoon and Edwin C. Glass and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

David L. Krasne

14 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy

1995 750 citations Armando E. Giuliano, Paul S. Dale et al. Annals of Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Krasne United States	9	1.1k	927	744	575	149	15	1.5k
Alberto Costa Italy	7	1.5k 1.3×	1.2k 1.3×	1.0k 1.4×	512 0.9×	155 1.0×	9	1.9k
Peter S. Turk United States	14	1.2k 1.1×	1.1k 1.2×	929 1.2×	494 0.9×	130 0.9×	15	1.7k
Ni Ni Ku United States	19	1.3k 1.2×	1.2k 1.2×	823 1.1×	426 0.7×	166 1.1×	34	1.6k
Marilia Bedoni Italy	6	1.6k 1.4×	1.3k 1.4×	992 1.3×	543 0.9×	164 1.1×	7	1.9k
Howard C. Snider United States	16	1.1k 1.0×	783 0.8×	567 0.8×	394 0.7×	99 0.7×	29	1.4k
C Berman United States	9	688 0.6×	552 0.6×	451 0.6×	786 1.4×	195 1.3×	12	1.4k
Masujiro Makita Japan	18	588 0.5×	500 0.5×	244 0.3×	447 0.8×	192 1.3×	69	1.0k
Celia Chao United States	13	540 0.5×	513 0.6×	492 0.7×	374 0.7×	62 0.4×	28	1.1k
Susanne H. Estourgie Netherlands	12	463 0.4×	390 0.4×	370 0.5×	363 0.6×	66 0.4×	20	910
Coral A. Quiet United States	22	1.5k 1.4×	724 0.8×	648 0.9×	456 0.8×	54 0.4×	48	1.8k

Countries citing papers authored by David L. Krasne

Since Specialization

Citations

This map shows the geographic impact of David L. Krasne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Krasne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Krasne more than expected).

Fields of papers citing papers by David L. Krasne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Krasne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Krasne. The network helps show where David L. Krasne may publish in the future.

Co-authorship network of co-authors of David L. Krasne

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Krasne. A scholar is included among the top collaborators of David L. Krasne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Krasne. David L. Krasne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bustos, Matías A., Kelly K. Chong, Yoko Koh, et al.. (2025). Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph‐node invasion. Clinical and Translational Medicine. 15(4). e70288–e70288.

Gottlieb, Josh, Shu‐Ching Chang, Gary L. Grunkemeier, et al.. (2023). Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection. Cancers. 15(14). 3707–3707. 2 indexed citations

Bustos, Matías A., Josh Gottlieb, Selena Y. Lin, et al.. (2023). Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients. Clinical Chemistry. 70(1). 261–272. 12 indexed citations

Koh, Yoko, Matías A. Bustos, Jamie Moon, et al.. (2022). Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients. Cancers. 14(10). 2388–2388. 8 indexed citations

Jain, Monica, David L. Krasne, Frederick R. Singer, & Armando E. Giuliano. (2016). Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis. Endocrine. 55(2). 643–650. 8 indexed citations

Bilchik, Anton J., Dean T. Nora, Leslie H. Sobin, et al.. (2003). Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer. Journal of Clinical Oncology. 21(4). 668–672. 60 indexed citations

Haigh, Philip I., Anthony Lucci, Roderick R. Turner, et al.. (2001). Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer. 92(3). 535–541. 60 indexed citations

Turner, Roderick R., Armando E. Giuliano, Dave S.�B. Hoon, Edwin C. Glass, & David L. Krasne. (2001). Pathologic Examination of Sentinel Lymph Node for Breast Carcinoma. World Journal of Surgery. 25(6). 798–805. 50 indexed citations

Turner, Roderick R., David W. Ollila, David L. Krasne, & Armando E. Giuliano. (1998). Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma. The Breast Journal. 4(1). 63–63. 1 indexed citations

10.

Turner, Roderick R., David W. Ollila, David L. Krasne, & Armando E. Giuliano. (1997). Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma. Annals of Surgery. 226(3). 271–278. 493 indexed citations

11.

Giuliano, Armando E., et al.. (1995). Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy. Annals of Surgery. 222(3). 394–401. 750 indexed citations breakdown →

12.

Krasne, David L., Wesley Y. Naritoku, & Michele Cosgrove. (1993). Diagnosis of syncytial (lacunar cell-predominant) nodular sclerosing Hodgkin's disease by fine needle aspiration. A case report.. PubMed. 37(3). 418–22. 7 indexed citations

13.

McDougall, I. Ross, David L. Krasne, John W. Hanbery, & Jannette Collins. (1989). Metastatic malignant struma ovarii presenting as paraparesis from a spinal metastasis.. PubMed. 30(3). 407–11. 32 indexed citations

14.

Krasne, David L., Roger A. Warnke, & Lawrence M. Weiss. (1988). Malignant Lymphoma Presenting as Pseudoepitheliomatous Hyperplasia. The American Journal of Surgical Pathology. 12(11). 835–842. 18 indexed citations

15.

Lombard, Charles, Henry D. Tazelaar, & David L. Krasne. (1987). Pulmonary Eosinophilia in Coccidioidal Infections. CHEST Journal. 91(5). 734–736. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact